Who are Palisade Bio, Inc.'s main suppliers?

Palisade Bio, Inc. (PALI) key suppliers include: GIIANT, ITERATIVE-SCOPES-INC-D-B-A-ITERATIVE-HEALTH, REGENTS-OF-THE-UNIVERSITY-OF-CALIFORNIA, Johnson & Johnson, Johnson & Johnson and 2 more. View the full supplier network at chainsifter.com/chain/PALI.

Who are Palisade Bio, Inc.'s major customers?

Palisade Bio, Inc. (PALI) key customers include: NEWSOARA, Johnson & Johnson, Johnson & Johnson, ORANY, ORANY. View the full customer network at chainsifter.com/chain/PALI.

What sector is Palisade Bio, Inc. in?

Palisade Bio, Inc. (PALI) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

PALI Supply Chain: Palisade Bio, Inc. Supplier List & 14 Relationships

7Suppliers

5Customers

2Debt Items

20Related Chains

Palisade Bio, Inc. Suppliers

Ticker	Name	Confidence	Evidence
GIIANT	GIIANT	92%	The Company has an obligation to make contingent consideration payments to Giiant, in either cash or shares of the Company’s common stock solely at the Company’s election, upon the achievement of dev…
ITERATIVE-SCOPES-INC-D-B-A-ITERATIVE-HEALTH	ITERATIVE-SCOPES-INC-D-B-A-ITERATIVE-HEALTH	90%	pursuant to which IH has agreed to, among other things, assist the Company with the Study Enrollment
REGENTS-OF-THE-UNIVERSITY-OF-CALIFORNIA	REGENTS-OF-THE-UNIVERSITY-OF-CALIFORNIA	80%	the Company entered into three license agreements, as amended, with the Regents of the University of California
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development…
JNJ	Johnson & Johnson	72%	oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
ORANY	ORANY	72%	oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from PALI graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis …

Palisade Bio, Inc. Customers

Ticker	Name	Confidence	Evidence
NEWSOARA	NEWSOARA	90%	During the three months ended March 31, 2026 and 2025, the Company recognized no license revenue from Newsoara under the Newsoara Co-Development Agreement.
JNJ	Johnson & Johnson	72%	oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development…
ORANY	ORANY	72%	oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Development: Design and development of stable and effective drug formulations suitable for c…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from PALI graph: oduction: High-quality synthesis of active ingredients under stringent regulatory standards. • Formulation Developme…

Palisade Bio, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
PALI-DEBT-11652	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2014-12-31.
PALI-DEBT-11651	Warrants outstanding: 644138	90%	xbrl warrant detail from xbrl 2026-03-31.

Palisade Bio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Palisade Bio, Inc..

Palisade Bio, Inc. Ownership

Holder	Name	Confidence	Evidence
PALI-OWNER-JANUS-HENDERSON-GROUP-PLC	JANUS HENDERSON GROUP PLC	90%	13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 98 tracked holders.

Palisade Bio, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
JNJ	Johnson & Johnson	100.00	1	['customer', 'supplier']
SNYNF	Sanofi	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AVTX	Avalo Therapeutics, Inc.	100.00	2
BLTE	Belite Bio, Inc	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AUMN	Golden Minerals Company	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
ANIK	Anika Therapeutics, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
AORT	Artivion, Inc.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
AVBP	ArriVent BioPharma, Inc.	50.00	2

Palisade Bio, Inc. Supply Chain